Showing results (91-100 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|July 30, 2021
Evaluating safety in hyaluronic acid lip injectionsTyler Safran, Arthur Swift, Sebastian Cotofana, et al.Expert Opinion on Drug Safety|June 9, 2021
Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndromeM E Gimbel, J M Ten BergExpert Opinion on Drug Safety|June 15, 2021
A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancyCarole A Marxer, Stephan Rüegg, Marlene S Rauch, et al.Expert Opinion on Drug Safety|June 24, 2022
Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trialYoichiro Hashimoto, Mika Komori, Yuka Tanji, et al.Expert Opinion on Drug Safety|June 17, 2022
A systematic review of digital technology and innovation and its potential to address anti-corruption, transparency, and accountability in the pharmaceutical supply chainGul Saeed, Jillian C Kohler, Raphael E Cuomo, et al.Expert Opinion on Drug Safety|December 16, 2020
Effect of drug interactions between carbapenems and valproate on serum valproate concentration: a systematic review and meta-analysisPony Yee-Chee Chai, Chian-Ting Chang, Yi-Hua Chen, et al.Expert Opinion on Drug Safety|January 4, 2021
Safety of current immune checkpoint inhibitors in non-small cell lung cancerPamela Abdayem, David PlanchardExpert Opinion on Drug Safety|January 4, 2021
A long-term open-label safety study of galcanezumab in Japanese patients with migraineKoichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.Expert Opinion on Drug Safety|May 28, 2021
Efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors as second-line treatment in postmenopausal patients with hormone receptor-positive, HER-2-negative metastatic breast cancer: a network meta-analysisJohn Hang Leung, Henry W C Leung, Shyh-Yau Wang, et al.Expert Opinion on Drug Safety|June 23, 2017
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosisMarinella Clerico, Carlo Alberto Artusi, Alessandra Di Liberto, et al.Pageof 281